# Ablative Therapy of Oligometastatic Tumor After Response to Conventional First Line Treatment

> **NCT07545486** · — · NOT_YET_RECRUITING · sponsor: **Chirec** · enrollment: 1235 (estimated)

## Conditions studied

- Solid Tumor

## Interventions

- **OTHER:** Data extraction from medical files

## Key facts

- **NCT ID:** NCT07545486
- **Lead sponsor:** Chirec
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2033-06-01
- **Final completion:** 2036-06-01
- **Target enrollment:** 1235 (ESTIMATED)
- **Last updated:** 2026-04-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07545486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07545486, "Ablative Therapy of Oligometastatic Tumor After Response to Conventional First Line Treatment". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07545486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*